von Tobias Borgers | Jan. 11, 2022 | Markt, Video - Continuous Manufacturing
We are pleased to introduce ourselves as a leading & trusted brand in the pharmaceutical Contract Manufacturing industry, M/S Maya Biotech a WHO, GMP & ISO 9001-2015 Certified Company. We have Dedicated Manufacturing Facilities in Baddi-Himachal Pradesh...
von Tobias Borgers | Jan. 4, 2022 | Glaxo
EMERYVILLE, Calif.–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK). The expansion will leverage...
von Tobias Borgers | Jan. 4, 2022 | Glaxo
September 13, 2021 | When Mike Montello joined the GSK team, the first steps of the pharma’s digital transformation had already taken place. His focus was to integrate the enterprise digital transformation to support another transformation taking place in R&D. “We...
von Tobias Borgers | Dez. 14, 2021 | Fachzeitschriften, Fette
Direktverpressung Ist die Direktverpressung der Königsweg in die Kontiproduktion? Die Vorteile des Continuous Manufacturing bei der Herstellung oraler fester Arzneiformen sind mittlerweile unumstritten. Wie die Direktverpressung den Weg in die Kontiproduktion ebnet,...
von Tobias Borgers | Dez. 10, 2021 | Continuous Manufacturing
Zeng Chuiyu, stellvertretender Direktor des Shanghai Pharmaceutical Manufacturing Management Center und Direktor des Technology Innovation Center, und Hu Shengli, Geschäftsführer von Syntegon in China, anlässlich der Unterzeichnung der Partnerschaftsvereinbarung....
